Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1990 Aug;19(2):94-125.
doi: 10.2165/00003088-199019020-00002.

Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II)

Affiliations
Review

Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II)

K Lauritsen et al. Clin Pharmacokinet. 1990 Aug.

Abstract

Part I of this article, which appeared in the previous issue of the Journal, covered the following agents: histamine H2-receptor antagonists (cimetidine, ranitidine, famotidine, nizatidine); muscarinic-M1-receptor antagonists (pirenzepine); proton pump inhibitors (omeprazole); site-protective agents (colloidal bismuth subcitrate, sucralfate); antacids and prostaglandin analogues; antiemetics and prokinetics (metoclopramide, domperidone, cisapride); and antispasmodics. In Part II, we consider the anti-inflammatory salicylates, nonspecific antidiarrhoeal agents, laxatives and cathartics.

PubMed Disclaimer

References

    1. Br J Clin Pharmacol. 1984 Sep;18(3):421-30 - PubMed
    1. Clin Pharmacol Ther. 1982 May;31(5):656-61 - PubMed
    1. Br J Clin Pharmacol. 1985 Dec;20(6):710-3 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1977 Nov;41(5):401-16 - PubMed
    1. Clin Pharmacol Ther. 1986 Jul;40(1):37-41 - PubMed

MeSH terms

LinkOut - more resources